These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28612327)

  • 1. The J-shaped Curve for Blood Pressure and Cardiovascular Disease Risk: Historical Context and Recent Updates.
    Rahman F; McEvoy JW
    Curr Atheroscler Rep; 2017 Aug; 19(8):34. PubMed ID: 28612327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dangers of Overly Aggressive Blood Pressure Control.
    Rahman F; McEvoy JW
    Curr Cardiol Rep; 2018 Sep; 20(11):108. PubMed ID: 30259274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Hypertension: Which Goal for Which Patient?
    Jarraya F
    Adv Exp Med Biol; 2017; 956():117-127. PubMed ID: 27722961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Diastolic Blood Pressure J-Curve in Hypertension Management: Links and Risk for Cardiovascular Disease.
    Gaffney B; Jacobsen AP; Pallippattu AW; Leahy N; McEvoy JW
    Integr Blood Press Control; 2021; 14():179-187. PubMed ID: 34938115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
    Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
    Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ambulatory Blood Pressure Monitoring (ABPM) as the reference standard for diagnosis of hypertension and assessment of vascular risk in adults.
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
    Chronobiol Int; 2015; 32(10):1329-42. PubMed ID: 26587588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management plans for populations with normal-to-hypertensive blood pressures: risks and benefits of antihypertensive drug treatment in populations previously defined as having high-normal blood pressure.
    Park S
    Korean J Intern Med; 2019 Jan; 34(1):44-49. PubMed ID: 30612417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Target values in hypertension treatment. Will they apply in older patients with hypertension, diabetics and in patients with IHD?].
    Widimský J
    Vnitr Lek; 2009 Sep; 55(9):833-40. PubMed ID: 19785385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the implications for the community of the discrepancy between the theory and practice of BP control?
    Jackson R
    J Hum Hypertens; 1995 Jul; 9 Suppl 2():S25-8. PubMed ID: 7562894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
    Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertension, coronary heart disease and stroke: should the blood pressure J-curve be a concern?].
    Nogueira JB
    Rev Port Cardiol; 2013 Feb; 32(2):139-44. PubMed ID: 23351918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. J-shaped curve for cardiovascular mortality: systolic or diastolic blood pressure?
    Robles NR; Fici F; Grassi G
    J Nephrol; 2019 Jun; 32(3):347-353. PubMed ID: 30225803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving blood pressure targets for prolonged cardiovascular health: a historical perspective.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2017 Jul; 15(7):517-523. PubMed ID: 28475386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood Pressure Parameters and their Associations with Death in Patients with Chronic Kidney Disease.
    Qureshi S; Lorch R; Navaneethan SD
    Curr Hypertens Rep; 2017 Oct; 19(11):92. PubMed ID: 29046987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The J-curve revisited: a therapeutic dilemma.
    Filippone EJ; Foy A
    Cardiol Rev; 2012; 20(5):253-8. PubMed ID: 22447043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a lower target blood pressure for people with heart disease.
    Rosendorff C; Black HR
    Curr Opin Cardiol; 2009 Jul; 24(4):318-24. PubMed ID: 19395951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefining blood pressure targets in high-risk patients?: lessons from coronary endpoints in recent randomized clinical trials.
    Volpe M; Tocci G
    Am J Hypertens; 2011 Oct; 24(10):1060-8. PubMed ID: 21677698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should blood pressure goal be individualized in hypertensive patients?
    Yannoutsos A; Kheder-Elfekih R; Halimi JM; Safar ME; Blacher J
    Pharmacol Res; 2017 Apr; 118():53-63. PubMed ID: 27919826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.